Gildon Choi

Daejeon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Design, synthesis and biological evaluation of symmetric thiadiazole carboxamide derivative as glutaminase inhibitor.

Design, synthesis and biological evaluation of symmetric thiadiazole carboxamide derivative as glutaminase inhibitor.

Journal: Bioorganic & medicinal chemistry letters

Published: January 21, 2026

Design, synthesis and biological evaluation of symmetric thiadiazole carboxamide derivative as glutaminase inhibitor.

Design, synthesis and biological evaluation of symmetric thiadiazole carboxamide derivative as glutaminase inhibitor.

Journal: Bioorganic & medicinal chemistry letters

Published: January 21, 2026

DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia.

DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia.

Journal: European journal of medicinal chemistry

Published: October 10, 2023

Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301.

Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301.

Journal: Cancers

Published: February 20, 2023

Novel allosteric glutaminase 1 inhibitors with macrocyclic structure activity relationship analysis.

Novel allosteric glutaminase 1 inhibitors with macrocyclic structure activity relationship analysis.

Journal: Bioorganic & medicinal chemistry letters

Published: June 21, 2022

The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia.

The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia.

Journal: Blood cancer journal

Published: January 07, 2022

Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection.

Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection.

Journal: Biomaterials

Published: June 01, 2021

Radicicol Inhibits Chikungunya Virus Replication by Targeting Nonstructural Protein 2.

Radicicol Inhibits Chikungunya Virus Replication by Targeting Nonstructural Protein 2.

Journal: Antimicrobial agents and chemotherapy

Published: April 27, 2021

A guide for bioinformaticians: 'omics-based drug discovery for precision oncology.

A guide for bioinformaticians: 'omics-based drug discovery for precision oncology.

Journal: Drug discovery today

Published: May 04, 2020

Discovery of novel [1,2,4]triazolo[4,3-a]quinoxaline aminophenyl derivatives as BET inhibitors for cancer treatment.

Discovery of novel [1,2,4]triazolo[4,3-a]quinoxaline aminophenyl derivatives as BET inhibitors for cancer treatment.

Journal: Bioorganic & medicinal chemistry letters

Published: July 21, 2017

BET Inhibitors as Anticancer Agents: A Patent Review.

BET Inhibitors as Anticancer Agents: A Patent Review.

Journal: Recent patents on anti-cancer drug discovery

Published: April 24, 2017

Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma.

Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma.

Journal: Oncotarget

Published: January 25, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026